Extracellular volume fraction quantification by equilibrium contrast-enhanced CT via automated segmentation predicts survival outcomes in bladder cancer: a propensity score-matched study

ECV can be used as a noninvasive biomarker to assist in the prognostic assessment of BLCA patients. Higher preoperative ECV indicates a poor prognosis for BLCA and requires aggressive treatment.